Close Menu
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Gulf Daily Report: The Gulf’s daily news, fully reported.Gulf Daily Report: The Gulf’s daily news, fully reported.
    • Home
    • Contact Us
    Gulf Daily Report: The Gulf’s daily news, fully reported.Gulf Daily Report: The Gulf’s daily news, fully reported.
    Home»PR Newswire»Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1
    PR Newswire

    Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

    September 9, 2024
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte
    • Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade II
    • Adheres to the WHO issued target product profiles and provides accurate detection of viral strains
    • Offers healthcare professionals with a critical tool in their research on the global spread of mpox by supporting international efforts

    SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ — Seegene Inc., a leading provider of total solution for PCR molecular diagnostics based in South Korea, announced today that it will introduce a new type of research-use-only (RUO) PCR assay to address the spread of the mpox virus variant, Clade Ib, which is currently prevalent in Africa.

    Seegene Expands mpox RUO Product Lineups: Novaplex™ MPXV/OPXV plus Assay (RUO)

    The newly introduced Novaplex™ MPXV/OPXV plus Assay (RUO) is designed to detect 3 targets causing mpox disease: non-variola Orthopoxvirus (OPXV) and mpox virus (MPVX) with specific confirmation of MPXV Clade I. MPXV Clade I is associated with higher transmission and mortality rates than MPXV Clade II.

    The assay meets the preferred target product profiles (TPPs) issued by the WHO, which guide manufacturers, suppliers, and researchers developing new assays for detection of viruses causing mpox. Additionally, it aligns with the preferred target analyte criteria for distinguishing between Clade I and II.

    Seegene has been responding swiftly to the August 2024 global public health emergency (PHEIC) declared by the WHO regarding the mpox outbreak by developing two assays designed to detect mpox virus and announcing plans to supply the products to countries in need.

    Among these, Novaplex™ MPXV/OPXV Assay (RUO) is designed to detect MPXV Clade I and Clade II as well as OPXV infections, while Novaplex™ HSV-1&2/VZV/MPXV Assay (RUO) is designed to simultaneously detect four viruses including MPXV, herpes simplex virus (HSV) Types 1 and 2, and varicella-zoster virus (VZV). These products also comply with TPPs issued by the WHO.

    “As the spread of mpox continues unabated, we have developed new RUO assays for detection of viruses causing the mpox to meet the increasing research demand from affected countries. We are committed to actively supporting global efforts to curb the spread of mpox,” said Daniel Shin, Executive Vice-President and Chief Global Sales and Marketing Officer at Seegene.

    In 2022, Seegene had previously leveraged its proprietary reagent development expertise and automated reagent development system (SGDDS) to create the Novaplex™ MPXV Assay (RUO).

    From January 2024 to September 6, 2024, there have been a total of 24,851 suspected cases, 5,549 confirmed cases and 643 deaths reported across the member states in the African Union (AU), according to the Africa Centres for Disease Control and Prevention (Africa CDC). The mpox variant is now spreading beyond African countries including Sweden, Pakistan, the Philippines, Jordan and Thailand.

    About Seegene 

    Seegene has 23 years of dedicated experience in R&D, manufacturing, and business related to multiplex PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene’s multiplex PCR technology is the ability to simultaneously test for 14 pathogens that cause similar symptoms in a single tube and provide quantitative information on the infection profile to correlate with the progression of illness.

    Visit: Seegene.com and follow linkedin.com/company/seegene-inc

    Logo

    Photo – https://mma.prnewswire.com/media/2499983/Photo__Seegene_Expands_mpox_RUO_Product_Lineups_with_Enhanced_Detection_Assays_for_Clade_1.jpg
    Logo – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/seegene-expands-mpox-ruo-product-lineups-with-enhanced-detection-assays-for-clade-1-302242213.html

    Related Posts

    Phoenix Contact Training Team Sets New Guinness World Record in Wiring

    November 16, 2026

    Thunes Expands Real-Time Payouts to Bhutan, Unlocking the Nation’s Remittance Market

    November 16, 2026

    WHO Bahrain and RCSI Medical University of Bahrain sign agreement to strengthen health workforce education, research and community engagement

    November 15, 2026

    Innovative Immunology Biotech Windward Bio Lists on Nasdaq

    November 14, 2026

    Alwaleed Philanthropies and The Research, Development and Innovation Authority Sign Strategic Partnership valued at SAR 10 million to Advance Innovation and Technology Solutions

    November 14, 2026

    81% of Software Teams Have Merged AI-Written Code They Didn’t Fully Understand, Finds TestMu AI’s State of AI in Quality Engineering 2026 Report

    November 13, 2026
    Latest News

    AfDB backs Morocco reforms and climate resilience with €434.4m

    November 14, 2026

    Sheikh Mohamed receives Arab League chief Nabil Fahmy

    November 14, 2026

    Three nations launch carbon crediting initiative at COP31

    November 13, 2026

    DP World partner ATI wins 25-year Manila port renewal

    November 13, 2026
    © 2026 Gulf Daily Report | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.